Table 3 Comparison of characteristics of patients in long-term (LT) group at baseline and after 6 months of withdrawal
Baseline | After 6 months | p | |
|---|---|---|---|
Body weight (kg) | 87 (75–103) 89.4 ± 15.8 | 87 (73–105) 91 ± 17.1 | 0.058 |
BMI (kg/m2) | 32.5 (27.7–38.8) 32.8 ± 5.7 | 32.5 (28.1–37.8) 33.4 ± 6.2 | 0.056 |
Waist circumference (cm) | 98 (92–110) | 102 (90–113) | 0.501 |
Systolic blood pressure (mmHg) | 118 (113–130) | 118 (111–122) | 0.211 |
Diastolic blood pressure (mmHg) | 87 (81–92) | 85 (74–86) | 0.010 |
No. of menstrual bleeding in last 6 month | 6 (6–6) | 6 (4–6) | 0.027 |
TFEQ-R18: cognitive restraint (%) | 66.7 (61.1–83.3) | 47.2 (37.5–61.1) | 0.003 |
TFEQ-R18: emotional eating (%) | 33.3 (11.1–55.6) | 33.3 (11.1–58.3) | 0.522 |
TFEQ-R18: uncontrolled eating (%) | 22.2 (7.4–44.4) | 29.6 (18.5–42.6) | 0.469 |
Total cholesterol (nmol/L) | 4.9 (4.3–5.3) | 4.9 (4.3–5.2) | 0.733 |
HDL (mmol/L) | 1.5 (1.2–1.8) | 1.6 (1.2–1.7) | 0.658 |
LDL (mmol/L) | 2.6 (2.3–3.2) | 2.5 (2.1–3.1) | 0.454 |
TG (mmol/L) | 1.3 (0.8–2.1) | 1.3 (0.8–1.9) | 0.874 |
FSH (IU/L) | 5.4 (3.9–7) | 5.4 (3.2–6.3) | 0.977 |
LH (IU/L) | 7.3 (2.7–11.1) | 6.1 (2.8–8.4) | 0.910 |
SHBG (nmol/L) | 42.2 (28.5–76.4) | 39.7 (32.5–56.5) | 0.925 |
Total testosterone (nmol/L) | 0.95 (0.69–1.1) | 0.73 (0.69–1.36) | 0.530 |
FAI score (%) | 2 (1–4) | 2 (2–3) | 0.752 |
Free testosterone (pmol/L) | 6.7 (4.4–8.4) | 6.9 (4.8–7.5) | 0.820 |
Androstenedione (nmol/L) | 6.4 (4.6–7.6) | 7.8 (4.8–9.6) | 0.053 |
Glucose OGTT 0 (mmol/L) | 5.1 (4.9–5.5) | 5.3 (4.7–5.6) | 0.800 |
Glucose OGTT 120 (mmol/L) | 5.9 (4.6–6.9) | 5.4 (4–6.5) | 0.233 |
Insulin OGTT 0 (mU/L) | 0.7 (0.5–1) | 0.6 (0.4–0.8) | 0.319 |
Insulin OGTT 120 (mU/L) | 40.7 (13.2–80.9) [ | 45.7 (43.1–81.3) | 0.826 |
HOMA-IR score | 1.4 (0.6–2.1) | 1.6 (0.5–2.7) | 0.875 |